Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Tamoxifen
100%
Temozolomide
100%
Glioma
100%
Cell Line
66%
Selective Estrogen Receptor Modulator
22%
Programmed Cell Death
22%
Estrogen Receptor
11%
DNA Methyltransferase
11%
Staining Technique
11%
NADH Dehydrogenase (Ubiquinone)
11%
Hoechst 33342
11%
Chemotherapy
11%
Methylation
11%
Keyphrases
Temozolomide Resistant
100%
ER+ Breast Cancer
33%
Direct Action
33%